Filing Details

Accession Number:
0001209191-23-056675
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-27 16:52:03
Reporting Period:
2023-11-22
Accepted Time:
2023-11-27 16:52:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1801777 Applied Molecular Transport Inc. AMTI Pharmaceutical Preparations (2834) 814481426
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1813286 Ph.d. Tahir Mahmood Amti C/O Corporation Trust Company,
Trust Center, 1209 Orange St
Wilmington DE 19801
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-11-22 286,320 $0.16 484,738 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,208,307 Indirect See Footnotes
Common Stock 391,693 Indirect See Footnotes
Footnotes
  1. Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person.
  2. The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1634 to $0.1638, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. These shares are held directly by the Mahmood-Shamsi Living Trust Agreement for which the Reporting Person and spouse serve as co-trustees and over which shares the Reporting Person and his spouse hold voting and dispositive power.
  4. These shares are held directly by The Mahmood 2017 Irrevocable Trust for which the Reporting Person serves as trustee and over which shares the Reporting Person hold voting and dispositive power.